LSIPR 50 2018: Tony Coles

06-08-2018

Tony Coles was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports.

tony-coles.jpg

 

 


Tony Coles, LSIPR 50 2018, Yumanity Therapeutics, Redmile Group, Alexandria Venture Investments, Biogen, Sanofi Ventures

LSIPR